RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Frazier Financial Advisors, LLC's Holding History (CIK: 0002002745)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024

Shares 250 Value ($000) $2 Avg Close $7.17 Range $5.88 - $8.73

Q2 2024

Shares 250 Value ($000) $2 Avg Close $8.72 Range $6.75 - $10.66

Q1 2024

Shares 250 Value ($000) $2 Avg Close $11.14 Range $8.68 - $15.74

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2024	250	$2	$7.17	$5.88 - $8.73
Q2 2024	250	$2	$8.72	$6.75 - $10.66
Q1 2024	250	$2	$11.14	$8.68 - $15.74